Early effect of PI3K-Akt-mTOR blockade on in vitro 18F-FDG uptake in HER2 breast cancer resistant to trastuzumab
Early effect of PI3K-Akt-mTOR blockade on in vitro 18F-FDG uptake in HER2 breast cancer resistant to trastuzumab
Update on the METABRIC consortium 2000 Breast Cancer Study
The Cancer Genome Atlas (TCGA): comprehensive molecular portraits of breast cancer
Genetic alterations in postmenopausal women with hormone receptor-positive, HER2-negative advanced breast cancer
Gene expression test distinguishes between breast cancer patients at high or low risk of late recurrence
Long-term effectiveness of SERMs for preventing breast cancer
Pursuing a career in palliative medicine
Involvement in the WIN Consortium
Implementation of individualised treatment and the WINTHER trial
The 2013 WIN Symposium
Importance of personalised medicine and the WIN Consortium
The role of physicians and researchers in the medical community